Rhonda D Cardin
Overview
Explore the profile of Rhonda D Cardin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tuttle J, Allais C, Allerton C, Anderson A, Arcari J, Aschenbrenner L, et al.
J Med Chem
. 2025 Feb;
PMID: 40019854
In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infections leading to COVID-19 disease reached a global level leading to the World Health Organization (WHO) declaration of a...
2.
Rosales R, McGovern B, Rodriguez M, Leiva-Rebollo R, Diaz-Tapia R, Benjamin J, et al.
Antiviral Res
. 2024 Jul;
230:105970.
PMID: 39067667
Variants of SARS-CoV-2 pose significant challenges in public health due to their increased transmissibility and ability to evade natural immunity, vaccine protection, and monoclonal antibody therapeutics. The emergence of the...
3.
Zhu Y, Yurgelonis I, Noell S, Yang Q, Guan S, Li Z, et al.
Sci Adv
. 2024 Jul;
10(30):eadl4013.
PMID: 39047088
To facilitate the detection and management of potential clinical antiviral resistance, in vitro selection of drug-resistant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) against the virus M inhibitor nirmatrelvir (Paxlovid...
4.
Allerton C, Arcari J, Aschenbrenner L, Avery M, Bechle B, Behzadi M, et al.
J Med Chem
. 2024 Apr;
67(16):13550-13571.
PMID: 38687966
Despite the record-breaking discovery, development and approval of vaccines and antiviral therapeutics such as Paxlovid, coronavirus disease 2019 (COVID-19) remained the fourth leading cause of death in the world and...
5.
Bonavita C, White T, Francis J, Farrell H, Davis-Poynter N, Cardin R
Viruses
. 2023 Mar;
15(3).
PMID: 36992420
Human cytomegalovirus (HCMV) is a ubiquitous pathogen that infects the majority of the world population and causes lifelong latent infection. HCMV has been shown to exacerbate cardiovascular diseases, including myocarditis,...
6.
White T, Bonavita C, Stanfield B, Farrell H, Davis-Poynter N, Cardin R
Front Immunol
. 2022 Dec;
13:1047299.
PMID: 36569845
Introduction: Human cytomegalovirus (HCMV) is a global health threat due to its ubiquity and lifelong persistence in infected people. During latency, host CD8 T cell responses to HCMV continue to...
7.
Lipka E, Chadderdon A, Harteg C, Doherty M, Simon E, Domagala J, et al.
Mol Pharm
. 2022 Dec;
20(1):370-382.
PMID: 36484496
DNA viruses are responsible for many diseases in humans. Current treatments are often limited by toxicity, as in the case of cidofovir (CDV, Vistide), a compound used against cytomegalovirus (CMV)...
8.
Gompels U, Bravo F, Briggs S, Ameri S, Cardin R, Bernstein D
Viruses
. 2022 Nov;
14(11).
PMID: 36366414
Herpes simplex virus 1 and 2 infections cause high unmet disease burdens worldwide. Mainly HSV-2 causes persistent sexually transmitted disease, fatal neonatal disease and increased transmission of HIV/AIDS. Thus, there...
9.
Zhu Y, Binder J, Yurgelonis I, Rai D, Lazarro S, Costales C, et al.
Antiviral Res
. 2022 Oct;
208:105429.
PMID: 36208677
Vero cells are widely used for antiviral tests and virology research for SARS-CoV-2 as well as viruses from various other families. However, Vero cells generally express high levels of multi-drug...
10.
White T, Stanfield B, Bonavita C, Rudd J, Cardin R
PLoS One
. 2022 Aug;
17(8):e0265479.
PMID: 35976883
The salivary glands are a crucial site of replication for human cytomegalovirus (HCMV) and its murine counterpart, murine cytomegalovirus (MCMV). Studies of MCMV often involve the use of BALB/c strain...